NEW YORK, December 19 /PRNewswire/ --

- Russia's Highest Commercial Court to Hear Appeal Argument Based on 'Newly Opened Circumstances' - a Question in Punctuation and an Allegedly Errant Hyphen;

- Hearing Set for January 22, 2008

Moscow Oil Refinery (MOR) is blocking New York businessman and real estate entrepreneur, Tamir Sapir, from executing the 2005 landmark US$28 million judgment initially decided by international arbitration and later upheld by Russia's High Arbitrazh Court after a protracted legal battle. The judgment against MOR was in favor of Mr. Sapir's company, Joy-Lud Distributors International Inc., a New York corporation.

EVRY, France, December 19 /PRNewswire/ --

- Not for Distribution in the United States, Canada or Japan

Novagali Pharma an emerging pharmaceutical company specialized in ophthalmology announces today the appointment of Dr Mourad Amrane as Vice President of Medical Affairs. He is in charge both of the clinical product development and the medical marketing activities, which aim at defining and optimizing the product strategies.

CARY, North Carolina, December 19 /PRNewswire/ --

- SciQuest Continues Rapid Worldwide Growth and Market Leadership among Research-Intensive Industries with 100th Customer Signing

MELBOURNE, Australia, December 19 /PRNewswire/ --

Cancer Therapeutics CRC Pty Ltd and the Queensland Institute of Medical Research (QIMR) today announced a collaboration to discover and develop new drugs for the treatment of many forms of cancer, based on exciting new findings in the field of DNA repair.

NORWICH, England, December 19 /PRNewswire/ --

- Less Than Half a Year Under New Ownership, Turnover for 2007 Expected to Increase by 34% on an Annual Basis

- Well Positioned for 2008 Thanks to Boosted Incoming Orders

- ATB CEO Christian Schmidt: "Turnaround is Truly Outstanding and was Achieved in far Shorter Time Than Originally Estimated"

Less than half a year under new ownership, the engineering company ATB Laurence Scott is well on track to achieve its former success. According to preliminary figures for the year 2007, the company expects to increase its turnover by 34% to GBP 18 mill. With an impressive flow of orders solid growth is set for 2008.

A research team at Maryland's A. James Clark School of Engineering comprised of Professor Christopher Davis, Research Scientist Igor Smolyaninov, and graduate student Yu-Ju Hung, has used plasmon technology to create the world's first invisibility cloak for visible light. The engineers have applied the same technology to build a revolutionary superlens microscope that allows scientists to see details of previously undetectable nanoscale objects.

Generally speaking, when we see an object, we see the visible light that strikes the object and is reflected. The Clark School team's invisibility cloak refracts (or bends) the light that strikes it, so that the light moves around and past the cloak, reflecting nothing, leaving the cloak and its contents "invisible."

Scientists long have focused on how climate and vegetation allowed human ancestors to evolve in Africa.

PERTH, Australia, December 19 /PRNewswire/ --

Nido Petroleum is pleased to announce that the appraisal programme for Galoc, the first offshore oil development in the Philippines for almost seven years, has been completed and the interim results look very positive.

Data acquired from the appraisal programme is undergoing petrophysical analysis combining the log and pressure data with the recovered core, the results of which will be used to optimise the placement of Galoc 3 in the southern portion of the field.

Whilst work is still ongoing, the results to date have confirmed the findings of the predevelopment studies.

DALLAS, December 19 /PRNewswire/ --

- Kingdom sought trusted vendor for national ID project, e-government rollout to protect 27 million citizens

A Virginia Commonwealth University Life Sciences Survey is the first poll to reflect the discovery reported internationally in November that human skin cells can be used to create stem cells or their near equivalents.

When asked about the implications of this development, more than six in 10, or 63 percent, say that both embryonic and non-embryonic stem cell research is still needed, 22 percent say this development means embryonic stem cell research is no longer necessary. Thirty-eight percent of Americans report hearing about this research.

Three-quarters of the U.S. public supports stem cell research that does not involve human embryos.